Navigation Links
HIV Patients May Have Stiffer Arteries
Date:6/26/2009

But not significant enough to halt drug therapy, researchers say

FRIDAY, June 26 (HealthDay News) -- HIV patients receiving highly active anti-retroviral therapy (HAART) are more likely to have a level of arterial stiffness similar to that in healthy patients with high blood pressure, a new study finds.

Arterial stiffness increases the risk of cardiovascular disease in people with high blood pressure.

The study provides new insight into the link between HIV infection, HAART use and the premature development of cardiovascular disease in HIV-infected patients, even when they have normal blood pressure.

However, the effects may not be severe enough to halt treatment, and the study didn't establish that HAART causes the stiffness, noted the researchers, from the University of Athens in Greece. The study appears online June 25 in the American Journal of Hypertension.

Previous studies have found that HIV patients treated with HAART had a higher level of arterial stiffness than HIV patients who weren't treated with HAART.

More information

The U.S. Food and Drug Administration has more about HIV/AIDS treatments.



-- Robert Preidt



SOURCE: American Journal of Hypertension, news release, June 25, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments
2. Research: Improving treatment of patients with heart attack
3. Bills Address Long Waits for Behavioral Health Patients
4. Effective pain treatment for cancer patients?
5. National Patients Rights Advocate Joins Truman Medical Centers as General Counsel
6. Forsyth Medical Center's Derrick L. Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast-Growing Brain Tumors
7. Sharp HealthCare and Anakam(R) Partner to Protect Patients Health Information
8. Grow Back Eyelashes - Orange County Plastic Surgeon Now Helps Patients Grow Longer, Fuller Darker Eyelashes With FDA-Approved Prescription Lash Treatment, Latisse
9. OPTIFAST(R) Program Pleases Patients With Innovative, Tasty Full Meal Replacement Bars
10. Care management reduces depression and suicidal thoughts in older primary care patients
11. Unique Facility Designed for the Comfort of Hospice Patients and Their Families
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Patients May Have Stiffer Arteries
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. ... DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig ... Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference ...
(Date:12/8/2016)... ... 2016 , ... SunView Software aims to redefine IT self-service ... engaging and easy to use. Coming off the heels of a successful launch ... plans to roll out new AI-powered self-service enhancements to help organizations implement effective ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... 2016 Mitsubishi Tanabe Pharma Corporation (Head Office: ... CEO: Dr. Masayuki Mitsuka ) has presented data ... edaravone intravenously in 10-14 day cycles for 48 weeks ... ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented ... in Dublin, Ireland . ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
Breaking Medicine Technology: